Sex: F
Vaccine: COVID19
Symptoms: Blood pressure measurement, Hypertension, Suspected product quality issue
Clinical narrative: he stated that his wife suffered the exact same increase in Blood Pressure about 158/92 after receiving Spikevax; Because his insurance agent's wife had the same exact side effects, he states, "I think you have got a problem with the new vaccine."; This spontaneous case was reported by a patient family member or friend and describes the occurrence of HYPERTENSION (he stated that his wife suffered the exact same increase in Blood Pressure about 158/92 after receiving Spikevax) and SUSPECTED PRODUCT QUALITY ISSUE (Because his insurance agent's wife had the same exact side effects, he states, "I think you have got a problem with the new vaccine.") in a female patient of an unknown age who received mRNA-1273.815 (SPIKEVAX 2023-2024) for COVID-19 prophylaxis.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273.815 (SPIKEVAX 2023-2024) (unknown route) 1 dosage form. On an unknown date, the patient experienced HYPERTENSION (he stated that his wife suffered the exact same increase in Blood Pressure about 158/92 after receiving Spikevax) and SUSPECTED PRODUCT QUALITY ISSUE (Because his insurance agent's wife had the same exact side effects, he states, "I think you have got a problem with the new vaccine."). At the time of the report, HYPERTENSION (he stated that his wife suffered the exact same increase in Blood Pressure about 158/92 after receiving Spikevax) and SUSPECTED PRODUCT QUALITY ISSUE (Because his insurance agent's wife had the same exact side effects, he states, "I think you have got a problem with the new vaccine.") outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Blood pressure measurement: about158/92.     The action taken with mRNA-1273.815 (SPIKEVAX 2023-2024) (Unknown) was unknown.   For mRNA-1273.815 (SPIKEVAX 2023-2024) (Unknown), the reporter did not provide any causality assessments.   Concomitant medication was not reported. After receiving Spikevax, patient had increase in blood pressure. Patient was scheduled to have a stress test done. Treatment medication was not reported.   This case was linked to US-MODERNATX, INC.-MOD-2023-748675.   Most recent FOLLOW-UP information incorporated above includes: On 08-Nov-2023: Quality complaint number added. On 08-Nov-2023: Added from subordinate duplicate case. Reference number added. On 08-Nov-2023: Added from subordinate duplicate case. Live Follow up received in which reference number added. On 08-Nov-2023: Upon internal review on 13-Nov-2023, it was identified that the case MOD-2023-748693 is duplicate of already existing case MOD-2023-748685. Hence, the case MOD-2023-748685 will be retained for further follow-up and all the information from the duplicate case MOD-2023-748693 has been incorporated into the retained case MOD-2023-748685. The duplicate case MOD-2023-748693 will be nullified and deleted from the safety database. On 13-Nov-2023: Live follow-up received with significant information. References added. On 13-Nov-2023: Reference numbers added. On 13-Nov-2023: Reference number added.; Sender's Comments:  US-MODERNATX, INC.-MOD-2023-748675:Different patient same product/reporter